Lifevantage Corporation
LFVN
Get informed when a big investor buys or sells
+ FollowMarket Cap$81.12M
Close$
$11.73
71.7% upside
Current Fair Value
71.7% upsideUndervalued by 71.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $81.12 Million |
|---|---|
| Enterprise Value | $78.84 Million |
| Dividend Yield | $0.18 (2.88%) |
| Earnings per Share | $0.8 |
| Beta | 0.76 |
| Outstanding Shares | 12,625,000 |
Return
| Return on Equity | 21.20% |
|---|---|
| Return on Assets | 11.38% |
| Return on Invested Capital | 20.46% |
Valuation & Multiples
| P/E Ratio | 13.92 |
|---|---|
| PEG | -22.92 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 3.42 |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | 9.17 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 6, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$47.77 M
Average shareholder expectationNext Earnings Call
Expected Date
September 3, 2026
EPS Estimate
$0.15
Average shareholder expectationRevenue Estimate
$43.97 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 25.31% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.23%▼ 43.86% |
|---|---|
| Total Invested | $12.79M▼ 60.98% |
| Investors Holding | 18▼ 89.00% |
ESG Score
No data
About Lifevantage Corporation
CEO: Darren Jensen LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...